Breast Cancer Research Program (BCRP) - Clinical Research Extension Award

The BCRP challenges the scientific community to design research that will address the urgency of ending breast cancer. Specifically, the BCRP seeks to accelerate high-impact research with clinical relevance, encourage innovation and stimulate creativity, and facilitate productive collaborations.

The FY23 BCRP Clinical Research Extension Award aims to extend or expand the data collection, follow-up, and analysis of breast cancer clinical studies. The intent of this mechanism is to increase the clinically relevant impact of breast cancer patient participation in clinical research by addressing the knowledge lost due to early trial termination, limited patient follow-up, or suboptimal sample and/or data collection and analysis.

Funding available up to $5M or $6M USD for the Partnering PI Option for a maximum of four years. Pre-Applications are required and must be submitted through eBRAP. Clinical trials not allowed.